Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly, Sepracor Pursue Non-Selective Antidepressants; (R)-Fluoxetine Dropped

Executive Summary

Lilly's termination of (R)-fluoxetine commits the company to developing non-selective agents to continue its presence in the antidepressant market.

You may also be interested in...



Sepracor Sales Force Expansion To 1,900 Planned For Up To 10 New Products

Sepracor plans to add more than 1,700 sales reps in the next three years to support upcoming product launches, President and COO William O'Shea announced during a Dec. 4 analyst conference.

Sepracor Sales Force Expansion To 1,900 Planned For Up To 10 New Products

Sepracor plans to add more than 1,700 sales reps in the next three years to support upcoming product launches, President and COO William O'Shea announced during a Dec. 4 analyst conference.

Wyeth Prevnar Coverage In Managed Care Tops 90%; Sales Top $200 Mil.

Wyeth-Ayerst expects the pneumococcal conjugate vaccine Prevnar to reach "full penetration of the U.S. market" during 2001.

Related Content

UsernamePublicRestriction

Register

PS036780

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel